SHP-624

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSHP-624
Drug Alias Nameheme B gene edit program (Shire)SHP-624
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFerrochelatase modulators
TargetsFerrochelatase
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A